Alcon Inc. (2U3)
XHAN
Closed
Oct 8, 2026
Day's Range
55.8052 wk Range
52.42Overview - 2U3 - Alcon Inc.
Key Statistics
Valuation
P/E (Trailing)
‪28.41‬
PEG Ratio
‪-0.28‬
Price / Book
‪1.27‬
Profitability
Gross Margin
‪59.33%‬
Profit Margin
‪55.23%‬
Operating Margin
‪13.11%‬
Return on Assets
‪3.10%‬
Return on Equity
‪4.45%‬
Ownership
Shares Outstanding
483.40M
Price stats
50-Day Avg
‪60.29‬
200-Day Avg
‪62.80‬
Dividends
Frequency
Annual
Peers - 2U3 - Alcon Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on XHAN.
- 2U3XHANAlcon Inc.-16.73%52-week change28.41P/E (Trailing)‪55.23%‬Profit Margin
- 6L8XHANPulse Biosciences, Inc.+42.34%52-week change-20.56P/E (Trailing)‪-54.00%‬Profit Margin
- 3737SXHAN37S+23.79%52-week change15.68P/E (Trailing)‪-17.46%‬Profit Margin
- WPSXHANWest Pharmaceutical Services Inc.+31.17%52-week change47.12P/E (Trailing)‪35.91%‬Profit Margin
- 6XTXHANAsahi Intecc Co., Ltd.+27.96%52-week change0.15P/E (Trailing)—Profit Margin
- SRT3XHANSartorius AG Preference Shares+24.79%52-week change114.91P/E (Trailing)‪46.26%‬Profit Margin
- SRTXHANSartorius AG+23.58%52-week change92.19P/E (Trailing)‪46.26%‬Profit Margin
Profile Summary - 2U3 - Alcon Inc.
About
Alcon Inc. is a global eye care company focused on products and technologies that support vision health across surgical and everyday care settings. Alcon Inc. develops, manufactures, and markets a broad portfolio for cataract surgery, vitreoretinal procedures, glaucoma care, refractive surgery, contact lenses, lens…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
